Vendor, Alameda, CA
Kairu Therapeutics Inc.
UEI J3NYGMYBR6M5, CAGE 15DH5
1 award and $350,000 obligated between January 30, 2026 and January 30, 2026, 0% under full and open competition, against 15.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $350,000 |
How it wins
Awards by competition, set-aside and type.
| Competed Under SAP | 1 |
| Definitive Contract | 1 |
Hear when Kairu Therapeutics Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Kairu Therapeutics Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $350,000
- Soonest
- January 29, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in biotechnology (except nanobiotechnology) to Defense Advanced Research Projects Agency, by dollars.
| Bifrost Biosystems Inc.Berkeley, CA | $2,469,502 |
| University of TennesseeKnoxville, TN | $748,000 |
| Council on Strategic Risks (The)Washington, DC | $356,648 |
| Repro-T CompanyArlington, MA | $349,997 |
| Seco Bio, Inc.Malden, MA | $310,000 |
| Polaris Quantum Biotech Inc.Cary, NC | $300,000 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HR001126CE019Definitive Contract, January 30, 2026, Competed Under SAP, 15 offers | Def Advanced Research Projects AgcyDefense Advanced Research Projects Agency | Embedded Entrepreneur Initiative (Eei)NAICS 541714, PSC B541 | $350,000 |
- Places of performance
- California
- Product and service codes
- B541 Defense Studies
- Transactions
- 1 across 1 awards